Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 6/20 | 1.00 |
| ▸ | SLC1A1 | P43005 | 6/20 | 1.00 |
| ▸ | SLC1A3 | P43003 | 5/20 | 1.00 |
| ▸ | GRIK1 | P39086 | 12/20 | 0.69 |
| ▸ | GRIK2 | Q13002 | 12/20 | 0.69 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL71719 | 1.00 | SLC1A2 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL27937270 | 1.00 | SLC1A2 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL7770487 | 1.00 | SLC1A2 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL30895 | 1.00 | SLC1A2 (1.00) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| Ethylene Glycol SCHEMBL28153823 | 0.94 | SLC1A1 (0.88) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| Glutamic Acid SCHEMBL1273613 | 0.87 | SLC1A2 (0.75) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL27467303 | 0.86 | SLC1A2 (0.76) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL20603228 | 0.86 | SLC1A2 (0.76) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL5324268 | 0.86 | SLC1A2 (0.76) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL751062 | 0.84 | SLC1A2 (0.71) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119390963-B | Polypeptide ester ether amine random polymer and preparation method and application thereof | 浙江大学 | 2025-04-29 | — | — | CN | claimed |
| CN-116333300-B | Method for preparing polytetrahydrofuran-polyamino acid block copolymer by activating rare earth triflate and product thereof | 浙江大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119390963-A | Polypeptide ester ether amine random polymer and preparation method and application thereof | 浙江大学 | 2025-02-07 | — | — | CN | claimed |
| CN-117624589-A | Random copolymerized amino acid containing glycine residue and synthesis method thereof | 浙江大学 | 2024-03-01 | — | — | CN | claimed |
| CN-116333300-A | Method for preparing polytetrahydrofuran-polyamino acid block copolymer by activating rare earth triflate and product thereof | 浙江大学 | 2023-06-27 | — | — | CN | claimed |
| CN-112188877-A | Design of tympanocentesis catheter or sub-annular ventilation catheter and other medical and fluid catheters | 哈佛学院院长及董事 | 2021-01-05 | — | — | CN | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| CN-122094980-A | Bispecific antibody fusion molecules targeting CD180 and CD3 and methods of use thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-121586731-A | Methods and uses of anti-CD 38T cell adaptor in treating peripheral T cell lymphoma | 赛诺菲 | 2026-02-27 | — | — | CN | disclosed |
| CN-120058907-A | Activin receptor type IIB variants and methods of use thereof | 科乐斯疗法公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-114585648-B | Binding members | 斯坎塞尔有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-115279786-B | SSEA-4 binding members | 斯坎塞尔有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-112292144-B | Activin receptor type IIB variants and methods of use thereof | 科乐斯疗法公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-1196436-A2 | PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE | Bristol-Myers Squibb Pharma Company (US) | 2002-04-17 | — | — | EP | disclosed |
| WO-2001064678-A2 | INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-09-07 | — | — | WO | disclosed |
| WO-2001040262-A1 | ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-06-07 | — | — | WO | disclosed |
| WO-2001002424-A2 | PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE | DU PONT PHARMACEUTICALS COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0787010-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996012499-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |